Session I: Targeting Therapies for Optimal Response

Moderator(s)

• 

  Marla Dubinsky, MD

Presentations:

• 7:30 AM – 7:40 AM

  Welcome and Introduction
  

  Moderator: Marla C. Dubinsky, MD – Icahn School of Medicine at Mount Sinai
• 7:40 AM – 8:00 AM

  Optimal Use of Integrins and Anti-TNFs for the Management of IBD
  

  Speaker: Ryan C. Ungaro, MD, MS – Icahn School of Medicine at Mount Sinai
• 8:00 AM – 8:20 AM

  Optimal Use and Future Use of JAK Inhibitors for the Management of IBD
  

  Speaker: David T. Rubin, MD, FACG – University of Chicago Medicine
• 8:20 AM – 8:40 AM

  Optimal Use and Future Use of IL12/23 for the Management of IBD
  

  Speaker: Bruce E. Sands, MD, MS, FACG – Icahn School of Medicine at Mount Sinai
• 8:40 AM – 9:10 AM

  Q&A Panel Discussion